Dr. Reddy's Laboratories Files Routine 6-K Report
Ticker: RDY · Form: 6-K · Filed: Oct 8, 2024 · CIK: 1135951
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
DRL filed a 6-K, standard procedure, no major news.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on October 8, 2024, to report information as a foreign private issuer. The filing does not contain specific financial figures or significant operational updates but serves as a routine disclosure to the SEC.
Why It Matters
This filing indicates Dr. Reddy's is fulfilling its ongoing reporting obligations as a publicly traded foreign company, ensuring transparency for investors.
Risk Assessment
Risk Level: low — The filing is a routine disclosure and does not contain any new material information that would immediately impact the company's risk profile.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Filer of the report
- SEC (company) — Recipient of the filing
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, typically to provide information that the registrant makes or is required to make public pursuant to the laws of its home country.
When was this Form 6-K filed?
This Form 6-K was filed on October 8, 2024.
What is the principal executive office address of Dr. Reddy's Laboratories Ltd.?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does Dr. Reddy's Laboratories Ltd. file annual reports under Form 20-F or 40-F?
Dr. Reddy's Laboratories Ltd. indicated that it files annual reports under cover of Form 20-F.
Does this filing contain specific financial results or operational updates?
Based on the provided text, this Form 6-K appears to be a routine disclosure and does not contain specific financial results or operational updates.
Filing Stats: 403 words · 2 min read · ~1 pages · Grade level 16.7 · Accepted 2024-10-08 07:41:19
Filing Documents
- drr0681_6k.htm (6-K) — 14KB
- drr0681_ex99-1.htm (EX-99.1) — 11KB
- drr0681_ex99-1img01.jpg (GRAPHIC) — 9KB
- drr0681_ex99-1img02.jpg (GRAPHIC) — 13KB
- drr0681_ex99-1img03.jpg (GRAPHIC) — 8KB
- 0001575872-24-001065.txt ( ) — 68KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: October 8, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3